Datopotamab Deruxtecan (Dato-DXd) in Combination With Pembrolizumab With or Without Platinum Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-Lung02)
Clinical trial NCT04526691 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04526691
- Sponsor
- Daiichi Sankyo
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-15
- Primary completion
- 2024-04-14
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.